Liability to substance use disorders: 1. Common mechanisms and manifestations.
about
Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspectiveA developmental perspective on alcohol and youths 16 to 20 years of ageRisk and resistance perspectives in translation-oriented etiology researchNicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug useDetermining non-cigarette tobacco, alcohol, and substance use typologies across menthol and non-menthol smokers using latent class analysisAssociation of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry CohortsFailure to sustain prepulse inhibition in adolescent marijuana usersQuick screen to detect current substance use disorder in adolescents and the likelihood of future disorder.Does stress mediate the development of substance use disorders among youth transitioning to young adulthood?Drug addiction and stress-response genetic variability: association study in African Americans.The AVPR1A gene and substance use disorders: association, replication, and functional evidence.Longitudinal trajectories of sensation seeking, risk taking propensity, and impulsivity across early to middle adolescence.The reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users.Meta-analysis of depression and substance use and impairment among cocaine users.Transitioning from DSM-IV abuse to dependence: the essence of harmful compulsive substance use is ontogenetic and dynamic.Drug Use among Residents of Juvenile Correctional Center in Kerman, Iran, and its Relationship with Personality Dimensions and Self-conceptMeasuring addiction propensity and severity: the need for a new instrumentDelay discounting differentiates pre-adolescents at high and low risk for substance use disorders based on family history.Common and drug-specific genetic influences on subjective effects to alcohol, tobacco and marijuana useAssessing TLI as a Predictor of Treatment Seeking for SUD among Youth Transitioning to Young Adulthood.Predictors of onset of cannabis and other drug use in male young adults: results from a longitudinal study.A new approach to researching the etiology of cannabis use disorder: integrating transmissible and nontransmissible risk within a developmental framework.Externalizing behavior and emotion dysregulation are indicators of transmissible risk for substance use disorderDifferent lengths of times for progressions in adolescent substance involvement.Measurement of the risk for substance use disorders: phenotypic and genetic analysis of an index of common liability.Deviant socialization mediates transmissible and contextual risk on cannabis use disorder development: a prospective study.Comorbidity and temporal relations of alcohol and cannabis use disorders from youth through adulthood.Could a continuous measure of individual transmissible risk be useful in clinical assessment of substance use disorder? Findings from the National Epidemiological Survey on Alcohol and Related ConditionsSleep and circadian contributions to adolescent alcohol use disorderDoes the Transmissible Liability Index (TLI) assessed in late childhood predict suicidal symptoms at young adulthood?Genetic relationship between the addiction diagnosis in adults and their childhood measure of addiction liabilitySeparate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC.Index of the transmissible common liability to addiction: heritability and prospective associations with substance abuse and related outcomesSex differences in self-report and behavioral measures of disinhibition predicting marijuana use across adolescence.Developmental momentum toward substance dependence: natural histories and pliability of risk factors in youth experiencing chronic stress.Genetic etiology of the common liability to drug dependence: evidence of common and specific mechanisms for DSM-IV dependence symptoms.Computer adaptive testing of liability to addiction: identifying individuals at risk.Does the "gateway" sequence increase prediction of cannabis use disorder development beyond deviant socialization? Implications for prevention practice and policy.Longitudinal Modeling of the Association Between Transmissible Risk, Affect During Drug Use and Development of Substance Use DisorderThe impact of emotional stress early in life on adult voluntary ethanol intake-results of maternal separation in rats.
P2860
Q24603044-1531A330-6FD6-475A-9508-FD8CEB122B82Q24650328-34A0A940-9178-4FB3-9908-777469D3727EQ26751398-98E68FB3-3E94-4B52-98DC-CB9E4A492D38Q26782271-217388DC-E617-40D4-A602-CAF33037C83CQ28468301-B91EDCFD-495B-4CDD-8B7A-3E76133FC6F4Q30316113-17A9612D-7610-4DDC-9378-FA2415CAB0F7Q30466085-168EA91B-F5B4-46C8-BDE7-923DD7CF1C40Q30531050-A3D30355-AA14-40A8-91B8-A9F3F4370D62Q33709027-9AB32DA1-1566-49CA-B0CA-8A0228F5C5DCQ33784764-8F6A5092-B5CE-4AE4-943A-22BE6BC02E03Q33852455-4EC31A4B-2FC6-4CA2-9257-EA531A3DAE3DQ33983241-EEC660E3-F189-45BF-8863-54CFE47F9EBEQ33989464-D81B4861-D968-4F51-ADEB-EC616B74043AQ34012500-33E8F3BD-258D-4838-A9B9-824BDCA7AF21Q34061451-85563989-C858-4153-91F6-1F075A729EF2Q34063890-256EEDCF-5A94-40A4-A323-086D56CFABE9Q34091899-5BD298B1-78FB-4F4F-8E30-B379B3A82BC2Q34167648-8785164F-3690-444E-BCE6-5DE4FE557DF5Q34424984-92DF7922-ED9F-4E94-93FC-094EAF14F298Q34448089-6C0D6376-31C0-4174-B914-AA8327FFD11DQ34587419-AAF564EE-F408-4B1D-A6BD-4C5CA6243900Q34714161-A0CDC2EF-CB86-4355-9C70-41FDC0CFDC5CQ34749082-1AA4EBD3-0FD2-4EEB-8CDC-123235A60EEBQ34928953-982C4E53-2963-4729-BBB0-8618B5223598Q34997165-5E774C31-9C24-4DD0-80E1-405A056B7D24Q35023958-9EE624CC-D223-4796-AF11-5E7A66817F17Q35181256-DF4A87E7-A5FC-4741-9709-D09BF9DD27B2Q35250493-AFAF37D9-BCBE-4310-BA11-139B5EBB0B85Q35582623-95D848EC-FA0E-4D07-8956-02E1A007BD0CQ35618764-0238EFCC-59E3-4438-9378-9FBFCEEBEB30Q35653685-028EC1D4-4DA1-4D62-BDCC-C6732D137ABEQ35840095-6A2BFE24-026B-4EB1-9C09-A4A2A5FB077DQ35899209-28B53426-21B0-4B47-9C85-2E044F3308B1Q35913435-CED78104-A3CC-4B9D-98E8-5195E6693EF7Q35928523-682C249B-FE62-4462-8B24-23774C313EB3Q35928700-FE8EC65E-DB48-47B2-9065-80F5DC5D80D7Q36016324-3C2193CD-F78A-4968-9709-299DFBB6BB26Q36069581-D490AE75-15BC-452D-A2DC-DED57AD8764AQ36240410-272D8ED6-C754-4DEF-A27B-991B46F654ADQ36329017-A55A5EC0-42B6-4741-BA5B-B7C2DC472C02
P2860
Liability to substance use disorders: 1. Common mechanisms and manifestations.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Liability to substance use disorders: 1. Common mechanisms and manifestations.
@ast
Liability to substance use disorders: 1. Common mechanisms and manifestations.
@en
Liability to substance use disorders: 1. Common mechanisms and manifestations.
@nl
type
label
Liability to substance use disorders: 1. Common mechanisms and manifestations.
@ast
Liability to substance use disorders: 1. Common mechanisms and manifestations.
@en
Liability to substance use disorders: 1. Common mechanisms and manifestations.
@nl
prefLabel
Liability to substance use disorders: 1. Common mechanisms and manifestations.
@ast
Liability to substance use disorders: 1. Common mechanisms and manifestations.
@en
Liability to substance use disorders: 1. Common mechanisms and manifestations.
@nl
P2093
P1476
Liability to substance use disorders: 1. Common mechanisms and manifestations.
@en
P2093
Brion S Maher
Duncan B Clark
Galina P Kirillova
Levent Kirisci
Michael M Vanyukov
Ralph E Tarter
P304
P356
10.1016/J.NEUBIOREV.2003.08.002
P577
2003-10-01T00:00:00Z